Rite Aid traded at $0.13 this Tuesday April 9th. Looking back, over the last four weeks, Rite Aid lost 85.71 percent. Over the last 12 months, its price fell by 94.51 percent. Looking ahead, we forecast Rite Aid to be priced at 0.13 by the end of this quarter and at 0.12 in one year, according to Trading Economics global macro models projections and analysts expectations.
Rite Aid Corporation is a healthcare company that operates retail drugstore chain. The Company is principally engaged in providing its service to customers and communities through various programs. Its business segments include Retail Pharmacy segment and Pharmacy Services segment. Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. Its Retail Pharmacy segment operates approximately 2,500 retail pharmacy locations across 19 states. Pharmacy Services segment provides a range of pharmacy benefit services through Elixir. Elixir also offers integrated mail-order and specialty pharmacy services through Elixir Pharmacy. The Pharmacy Services segment provides both transparent and traditional pharmacy benefit management (PBM) options through its Elixir PBM. The Company's clients include employers, insurance companies and unions.